Scientists at the Walter Reed Army Institute of Research have developed a COVID-19 vaccine that could protect people against SARS-origin viruses and future coronavirus strains as well using the Spike Ferritin Nanoparticle (SpFN).
“We decided to take a look at the long game rather than just only focusing on the original emergence of SARS, and instead understand that viruses mutate, there will be variants that emerge, future viruses that may emerge in terms of new species,” said Dr. Kayvon Modjarrad, director of Walter Reed’s infectious diseases branch.
SpFN uses a soccer-ball-shaped protein with 24 facets that can accommodate multiple coronavirus strains.
The Army started developing SpFN in early 2020 and has already completed Phase 1 human trials.
According to the Phase 1 results, the SpFN vaccine creates both a strong immune response and broad protection against multiple COVID and SARS variants.
“With Omicron, there’s no way really to escape this virus.You’re not going to be able to avoid it. So I think pretty soon either the whole world will be vaccinated or have been infected,” said Modjarrad.
There is no information on when the army plans on submitting their trial data to the FDA.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.